Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
35.47
+1.34 (3.93%)
At close: Jun 26, 2026, 4:00 PM EDT
35.48
+0.01 (0.03%)
After-hours: Jun 26, 2026, 7:30 PM EDT
HRMY Employees
Harmony Biosciences Holdings had 293 employees as of December 31, 2025. The number of employees increased by 25 or 9.33% compared to the previous year.
Employees
293
Change (1Y)
25
Growth (1Y)
9.33%
Revenue / Employee
$3,068,625
Profits / Employee
$496,980
Market Cap
2.05B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| ADMA Biologics | 647 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 307 |
| Viridian Therapeutics | 252 |
| Kardigan | 241 |
| Stoke Therapeutics | 170 |
| Precigen | 160 |
HRMY News
- 13 days ago - 20 growth stocks priced as value stocks - Market Watch
- 17 days ago - Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting - Business Wire
- 19 days ago - Harmony Biosciences Holdings Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Harmony Biosciences Holdings Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Harmony Biosciences price target raised to $29 from $25 at Truist - TheFly
- 7 weeks ago - Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.02B - TheFly
- 7 weeks ago - Harmony Biosciences Holdings Earnings Call Transcript: Q1 2026 - Transcripts